Sub-therapeutic GnRH- Antagonist Treatment to Rectify LH Pulsatility in Lean Women With PCOS.

NCT05751252 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Ovary Syndrome

Interventions

DRUG: Ganirelix
DRUG: Ganirelix

Sponsor

University Hospital, Lille